ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene …

ReCODE creates a personalized plan based on your medical history, genetics, and biomarkers to restore brain health by addressing the root causes of cognitive decline. ReCODE is built on decades …

Nov 11, 2025 · The most important part of the [ReCODE] protocol … is that the improvement is sustained. You're actually going after the root cause of what is causing the cognitive decline.

Recode (stylized as recode; formerly Re/code) [1] was a technology news website that focused on the business of Silicon Valley. Walt Mossberg and Kara Swisher founded it in January 2014, after they …

What is the ReCODE Program? The ReCODE™ (Reversal of Cognitive Decline) program, developed by Dr. Dale Bredesen, is a cutting-edge approach to slowing or reversing cognitive decline.

Sep 29, 2021 · Using a novel, comprehensive, and personalized therapeutic system called ReCODE (reversal of cognitive decline), which proved successful in a small, proof-of-concept trial, we sought …

The ReCODE program looks at genetic factors, lifestyle factors, toxin exposures, and nutritional and hormone deficiencies and, by addressing multiple contributors, can reverse early Alzheimer’s …

ReCODE (reversing cognitive decline) and PreCODE (prevention of cognitive decline) are personalized therapeutic programs that target and treat the root cause of cognitive decline and degenerative …

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.

With the versatility of genetic cargo and flexibility in administration, ReCode’s SORT LNP technology has potential applications across many genetically defined conditions, including muscular, CNS, liver, …